A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.